SE9002659D0 - New pharmaceutical formulations - Google Patents
New pharmaceutical formulationsInfo
- Publication number
- SE9002659D0 SE9002659D0 SE9002659A SE9002659A SE9002659D0 SE 9002659 D0 SE9002659 D0 SE 9002659D0 SE 9002659 A SE9002659 A SE 9002659A SE 9002659 A SE9002659 A SE 9002659A SE 9002659 D0 SE9002659 D0 SE 9002659D0
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical formulations
- new pharmaceutical
- new
- methylthiazole
- solvate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002659A SE9002659D0 (sv) | 1990-08-15 | 1990-08-15 | New pharmaceutical formulations |
EP91915138A EP0619734B1 (en) | 1990-08-15 | 1991-08-07 | New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole |
HU9300388A HUT65821A (en) | 1990-08-15 | 1991-08-07 | Process for preparing anti-neurodegenerative pharmaceutical preparations containing 5-(chloro-1-hydroxyethyl)-4-methylthiazole |
AT91915138T ATE164066T1 (de) | 1990-08-15 | 1991-08-07 | Neue pharmazeutische formulierungen von 5-(2- chlor-1-hydroxyethyl)-4-methylthiazol |
JP03514007A JP3094077B2 (ja) | 1990-08-15 | 1991-08-07 | 5−(2−クロロ−1−ヒドロキシエチル)−4−メチルチアゾール含有の医薬製剤 |
SK8793A SK8793A3 (en) | 1990-08-15 | 1991-08-07 | New pharmaceutical formulations of 5-(2-chlor-1-hydroxyethyl)-4-methylthiazole |
ES91915138T ES2114891T3 (es) | 1990-08-15 | 1991-08-07 | Nuevas formulaciones farmaceuticas de 5-(2-cloro-1-hidroxietil)-4-metiltiazol. |
CA002088775A CA2088775A1 (en) | 1990-08-15 | 1991-08-07 | Pharmaceutical formulations of 5- (2-chloro-1-hydroxyethyl)-4-methylthiazole |
DK91915138T DK0619734T3 (da) | 1990-08-15 | 1991-08-07 | Nye farmaceutiske formuleringer af 5-(2-chlor-1-hydroxyethyl)-4-methylthiazol |
PCT/SE1991/000522 WO1992003134A1 (en) | 1990-08-15 | 1991-08-07 | New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole |
AU84092/91A AU657490B2 (en) | 1990-08-15 | 1991-08-07 | 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole |
RO93-00194A RO112994B1 (ro) | 1990-08-15 | 1991-08-07 | Metoda pentru prevenirea si tratarea degenerarilor neurologice |
DE69129126T DE69129126T2 (de) | 1990-08-15 | 1991-08-07 | Neue pharmazeutische formulierungen von 5-(2-chlor-1-hydroxyethyl)-4-methylthiazol |
RU9193004984A RU2093155C1 (ru) | 1990-08-15 | 1991-08-07 | Применение 5-[2-хлор-1-гидроксиэтил]-4-метилтиазола для снижения поражения нейронов, подавления конвульсий и снижения двигательной активности |
CS93166A CZ279586B6 (cs) | 1990-08-15 | 1991-08-07 | Nové farmaceutické prostředky z 5-(2-chlor-1-hydroxyethyl)-4-methylthiazolu |
NZ239329A NZ239329A (en) | 1990-08-15 | 1991-08-09 | 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole and its salts, pharmaceutical compositions thereof |
IE281891A IE912818A1 (en) | 1990-08-15 | 1991-08-09 | New pharmaceutical formulations |
IL9916991A IL99169A (en) | 1990-08-15 | 1991-08-12 | Medicinal products containing 4-methylthiazole |
IS3743A IS3743A7 (is) | 1990-08-15 | 1991-08-14 | Ný notkun á 5-(2 klóró-1-hýdroxíetýl)-4-metýlþíasól |
PT98688A PT98688B (pt) | 1990-08-15 | 1991-08-14 | Processo para a preparacao de composicoes farmaceuticas contendo 5-(2-cloro-1-hidroxietil)-4-metiltiazol |
US07/744,914 US5385921A (en) | 1990-08-15 | 1991-08-14 | Pharmaceutical formulations |
NO930452A NO303447B1 (no) | 1990-08-15 | 1993-02-09 | AnalogifremgangsmÕte for fremstilling av et terapeutisk aktivt hydrokloridsalt eller etandisulfonatsalt av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol |
FI930608A FI930608A (fi) | 1990-08-15 | 1993-02-11 | Nya farmaceutiska formulationer av 5-(2-klor-1-hydroxietyl)-4-metyltiazol |
BG97446A BG97446A (en) | 1990-08-15 | 1993-02-15 | Pharmaceutical compositions of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole |
LVP-93-1024A LV10921B (en) | 1990-08-15 | 1993-08-10 | Novel pharmaceutical formulations |
LTIP1714A LT3978B (en) | 1990-08-15 | 1993-12-30 | New pharmaceutical formulations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002659A SE9002659D0 (sv) | 1990-08-15 | 1990-08-15 | New pharmaceutical formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9002659D0 true SE9002659D0 (sv) | 1990-08-15 |
Family
ID=20380161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9002659A SE9002659D0 (sv) | 1990-08-15 | 1990-08-15 | New pharmaceutical formulations |
Country Status (26)
Country | Link |
---|---|
US (1) | US5385921A (xx) |
EP (1) | EP0619734B1 (xx) |
JP (1) | JP3094077B2 (xx) |
AT (1) | ATE164066T1 (xx) |
AU (1) | AU657490B2 (xx) |
BG (1) | BG97446A (xx) |
CA (1) | CA2088775A1 (xx) |
CZ (1) | CZ279586B6 (xx) |
DE (1) | DE69129126T2 (xx) |
DK (1) | DK0619734T3 (xx) |
ES (1) | ES2114891T3 (xx) |
FI (1) | FI930608A (xx) |
HU (1) | HUT65821A (xx) |
IE (1) | IE912818A1 (xx) |
IL (1) | IL99169A (xx) |
IS (1) | IS3743A7 (xx) |
LT (1) | LT3978B (xx) |
LV (1) | LV10921B (xx) |
NO (1) | NO303447B1 (xx) |
NZ (1) | NZ239329A (xx) |
PT (1) | PT98688B (xx) |
RO (1) | RO112994B1 (xx) |
RU (1) | RU2093155C1 (xx) |
SE (1) | SE9002659D0 (xx) |
SK (1) | SK8793A3 (xx) |
WO (1) | WO1992003134A1 (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9901658D0 (sv) * | 1999-05-06 | 1999-05-06 | Astra Ab | New formulation |
SE9904177D0 (sv) * | 1999-11-18 | 1999-11-18 | Astra Ab | Novel compounds |
AU2002314744A1 (en) | 2001-04-17 | 2002-10-28 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
CN103772313B (zh) * | 2014-01-02 | 2015-10-14 | 郑桂富 | 一种4-甲基-5-(2-羟乙基)噻唑的合成方法 |
CN112262814A (zh) * | 2020-10-26 | 2021-01-26 | 宜宾学院 | 油樟叶渣发酵床养鸡方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2825966A1 (de) * | 1978-06-14 | 1980-01-03 | Basf Ag | Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt |
GB8600783D0 (en) * | 1986-01-14 | 1986-02-19 | Merck Sharp & Dohme | N-methyl-d-aspartate receptor antagonists |
-
1990
- 1990-08-15 SE SE9002659A patent/SE9002659D0/xx unknown
-
1991
- 1991-08-07 RU RU9193004984A patent/RU2093155C1/ru active
- 1991-08-07 DK DK91915138T patent/DK0619734T3/da active
- 1991-08-07 AU AU84092/91A patent/AU657490B2/en not_active Ceased
- 1991-08-07 AT AT91915138T patent/ATE164066T1/de not_active IP Right Cessation
- 1991-08-07 WO PCT/SE1991/000522 patent/WO1992003134A1/en active IP Right Grant
- 1991-08-07 RO RO93-00194A patent/RO112994B1/ro unknown
- 1991-08-07 JP JP03514007A patent/JP3094077B2/ja not_active Expired - Lifetime
- 1991-08-07 EP EP91915138A patent/EP0619734B1/en not_active Expired - Lifetime
- 1991-08-07 CZ CS93166A patent/CZ279586B6/cs unknown
- 1991-08-07 HU HU9300388A patent/HUT65821A/hu unknown
- 1991-08-07 DE DE69129126T patent/DE69129126T2/de not_active Expired - Lifetime
- 1991-08-07 SK SK8793A patent/SK8793A3/sk unknown
- 1991-08-07 CA CA002088775A patent/CA2088775A1/en not_active Withdrawn
- 1991-08-07 ES ES91915138T patent/ES2114891T3/es not_active Expired - Lifetime
- 1991-08-09 IE IE281891A patent/IE912818A1/en unknown
- 1991-08-09 NZ NZ239329A patent/NZ239329A/en unknown
- 1991-08-12 IL IL9916991A patent/IL99169A/en active IP Right Grant
- 1991-08-14 IS IS3743A patent/IS3743A7/is unknown
- 1991-08-14 US US07/744,914 patent/US5385921A/en not_active Expired - Lifetime
- 1991-08-14 PT PT98688A patent/PT98688B/pt not_active IP Right Cessation
-
1993
- 1993-02-09 NO NO930452A patent/NO303447B1/no not_active IP Right Cessation
- 1993-02-11 FI FI930608A patent/FI930608A/fi unknown
- 1993-02-15 BG BG97446A patent/BG97446A/xx unknown
- 1993-08-10 LV LVP-93-1024A patent/LV10921B/en unknown
- 1993-12-30 LT LTIP1714A patent/LT3978B/lt not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9102473A (es) | Agentes farmaceuticos. | |
FI933248A0 (fi) | Optiskt aktiva 5h-pyrrolo(3,4-b)pyrazinderat, dess framstaellning och farmaceutiska kompositioner innehaollande detta | |
DK0535034T3 (da) | Farmaceutisk aktive benzoquinazolinforbindelser | |
NO180445C (no) | 2-(4-hydroksypiperidino)-1-alkanol-derivater som anti-iskemiske midler | |
SE9002659D0 (sv) | New pharmaceutical formulations | |
FI882965A (fi) | Aminocyklopentyletrar och deras framstaellning och farmaceutiska preparat. | |
FI923371A0 (fi) | En farmaceutisk formulation. | |
DE69013131D1 (de) | 2-(2-Cyclopropylpyrrolidin-4-ylthio)carbapenemderivate. | |
NO306381B1 (no) | Farmasöytisk ampulle | |
RU93004984A (ru) | Фармацевтическая композиция на основе 5(2-хлор-1-гидроксиэтил)-4-метилтиазола, применение 5-(2-хлор-1-гидроксиэтил)-4-метил-тиазола для лечения, способ лечения, соли 5-(2-хлор-1-гидроксиэтил)-4-метилтиазола | |
SE9000948D0 (sv) | New use | |
FI910773A0 (fi) | Farmaceutisk komposition innehaollande ett episialo-kolhydratkomplex. | |
FI930967A0 (fi) | Substituerade 6,7-dihydroimidazo(1,5,4-ef)(1,5)bensodiazepin-6-oner, deras framstaellning och farmaceutiska kompositioner | |
DE69104013D1 (de) | Hexitolderivate. | |
SE9000288D0 (sv) | New use | |
ITMI911049A0 (it) | Composizione oftalmica | |
MX9203359A (es) | Nuevas composiciones farmaceuticas de insulina. | |
MX9202442A (es) | Derivados de azol. | |
FI971316A0 (fi) | Farmaseuttinen yhdiste | |
NO903685D0 (no) | Dobbeltmuffe. | |
ITRM910200A0 (it) | Procedimento per la produzione di lenti oftalmiche a contatto. |